nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—ABCG2—Omeprazole—Barrett's esophagus	0.151	0.247	CbGbCtD
Regorafenib—CYP2C19—Esomeprazole—Barrett's esophagus	0.115	0.187	CbGbCtD
Regorafenib—CYP2C8—Omeprazole—Barrett's esophagus	0.0806	0.131	CbGbCtD
Regorafenib—CYP2C19—Omeprazole—Barrett's esophagus	0.0676	0.11	CbGbCtD
Regorafenib—CYP2C9—Omeprazole—Barrett's esophagus	0.0562	0.0917	CbGbCtD
Regorafenib—CYP3A4—Esomeprazole—Barrett's esophagus	0.0555	0.0904	CbGbCtD
Regorafenib—ABCB1—Omeprazole—Barrett's esophagus	0.0546	0.089	CbGbCtD
Regorafenib—CYP3A4—Omeprazole—Barrett's esophagus	0.0327	0.0533	CbGbCtD
Regorafenib—FGFR2—exocrine gland—Barrett's esophagus	0.00674	0.0695	CbGeAlD
Regorafenib—DDR2—smooth muscle tissue—Barrett's esophagus	0.00553	0.057	CbGeAlD
Regorafenib—KIT—exocrine gland—Barrett's esophagus	0.00468	0.0483	CbGeAlD
Regorafenib—Polyp—Omeprazole—Barrett's esophagus	0.00453	0.0251	CcSEcCtD
Regorafenib—Polyp—Esomeprazole—Barrett's esophagus	0.00453	0.0251	CcSEcCtD
Regorafenib—DDR2—digestive system—Barrett's esophagus	0.00436	0.045	CbGeAlD
Regorafenib—Hypomagnesaemia—Omeprazole—Barrett's esophagus	0.00434	0.0241	CcSEcCtD
Regorafenib—Hypomagnesaemia—Esomeprazole—Barrett's esophagus	0.00434	0.0241	CcSEcCtD
Regorafenib—Cyst—Omeprazole—Barrett's esophagus	0.00413	0.0229	CcSEcCtD
Regorafenib—Cyst—Esomeprazole—Barrett's esophagus	0.00413	0.0229	CcSEcCtD
Regorafenib—FLT4—epithelium—Barrett's esophagus	0.00349	0.0361	CbGeAlD
Regorafenib—Proteinuria—Esomeprazole—Barrett's esophagus	0.00314	0.0174	CcSEcCtD
Regorafenib—Proteinuria—Omeprazole—Barrett's esophagus	0.00314	0.0174	CcSEcCtD
Regorafenib—Protein urine present—Omeprazole—Barrett's esophagus	0.0031	0.0172	CcSEcCtD
Regorafenib—Protein urine present—Esomeprazole—Barrett's esophagus	0.0031	0.0172	CcSEcCtD
Regorafenib—RET—epithelium—Barrett's esophagus	0.00309	0.0318	CbGeAlD
Regorafenib—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.00305	0.0169	CcSEcCtD
Regorafenib—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.00305	0.0169	CcSEcCtD
Regorafenib—Hyperbilirubinaemia—Omeprazole—Barrett's esophagus	0.00303	0.0168	CcSEcCtD
Regorafenib—Hyperbilirubinaemia—Esomeprazole—Barrett's esophagus	0.00303	0.0168	CcSEcCtD
Regorafenib—Hypocalcaemia—Esomeprazole—Barrett's esophagus	0.00301	0.0167	CcSEcCtD
Regorafenib—Hypocalcaemia—Omeprazole—Barrett's esophagus	0.00301	0.0167	CcSEcCtD
Regorafenib—Hyperuricaemia—Omeprazole—Barrett's esophagus	0.00297	0.0165	CcSEcCtD
Regorafenib—Hyperuricaemia—Esomeprazole—Barrett's esophagus	0.00297	0.0165	CcSEcCtD
Regorafenib—FGFR2—epithelium—Barrett's esophagus	0.00293	0.0302	CbGeAlD
Regorafenib—EPHA2—epithelium—Barrett's esophagus	0.00288	0.0297	CbGeAlD
Regorafenib—FGFR2—smooth muscle tissue—Barrett's esophagus	0.00282	0.0291	CbGeAlD
Regorafenib—TEK—epithelium—Barrett's esophagus	0.00281	0.029	CbGeAlD
Regorafenib—Blood uric acid increased—Esomeprazole—Barrett's esophagus	0.00281	0.0156	CcSEcCtD
Regorafenib—Blood uric acid increased—Omeprazole—Barrett's esophagus	0.00281	0.0156	CcSEcCtD
Regorafenib—FLT1—epithelium—Barrett's esophagus	0.00272	0.028	CbGeAlD
Regorafenib—TEK—smooth muscle tissue—Barrett's esophagus	0.00271	0.0279	CbGeAlD
Regorafenib—RAF1—epithelium—Barrett's esophagus	0.0027	0.0279	CbGeAlD
Regorafenib—UGT1A9—digestive system—Barrett's esophagus	0.0027	0.0278	CbGeAlD
Regorafenib—FLT1—smooth muscle tissue—Barrett's esophagus	0.00262	0.027	CbGeAlD
Regorafenib—RAF1—smooth muscle tissue—Barrett's esophagus	0.0026	0.0269	CbGeAlD
Regorafenib—Neoplasm—Omeprazole—Barrett's esophagus	0.00249	0.0138	CcSEcCtD
Regorafenib—Neoplasm—Esomeprazole—Barrett's esophagus	0.00249	0.0138	CcSEcCtD
Regorafenib—PDGFRA—smooth muscle tissue—Barrett's esophagus	0.00245	0.0253	CbGeAlD
Regorafenib—RET—digestive system—Barrett's esophagus	0.00235	0.0242	CbGeAlD
Regorafenib—KDR—epithelium—Barrett's esophagus	0.0023	0.0237	CbGeAlD
Regorafenib—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00226	0.0125	CcSEcCtD
Regorafenib—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00226	0.0125	CcSEcCtD
Regorafenib—FGFR2—digestive system—Barrett's esophagus	0.00223	0.023	CbGeAlD
Regorafenib—KDR—smooth muscle tissue—Barrett's esophagus	0.00221	0.0228	CbGeAlD
Regorafenib—EPHA2—digestive system—Barrett's esophagus	0.00219	0.0226	CbGeAlD
Regorafenib—FLT1—digestive system—Barrett's esophagus	0.00207	0.0213	CbGeAlD
Regorafenib—RAF1—digestive system—Barrett's esophagus	0.00206	0.0212	CbGeAlD
Regorafenib—KIT—epithelium—Barrett's esophagus	0.00204	0.021	CbGeAlD
Regorafenib—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00201	0.0111	CcSEcCtD
Regorafenib—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00201	0.0111	CcSEcCtD
Regorafenib—PDGFRB—epithelium—Barrett's esophagus	0.00199	0.0205	CbGeAlD
Regorafenib—KIT—smooth muscle tissue—Barrett's esophagus	0.00196	0.0202	CbGeAlD
Regorafenib—PDGFRA—digestive system—Barrett's esophagus	0.00194	0.02	CbGeAlD
Regorafenib—PDGFRB—smooth muscle tissue—Barrett's esophagus	0.00192	0.0198	CbGeAlD
Regorafenib—UGT1A1—digestive system—Barrett's esophagus	0.00185	0.0191	CbGeAlD
Regorafenib—Dry skin—Esomeprazole—Barrett's esophagus	0.00184	0.0102	CcSEcCtD
Regorafenib—Dry skin—Omeprazole—Barrett's esophagus	0.00184	0.0102	CcSEcCtD
Regorafenib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00182	0.0101	CcSEcCtD
Regorafenib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00182	0.0101	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.0018	0.01	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.0018	0.01	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.0018	0.01	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.0018	0.01	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00177	0.00979	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00177	0.00979	CcSEcCtD
Regorafenib—KDR—digestive system—Barrett's esophagus	0.00175	0.018	CbGeAlD
Regorafenib—ABL1—smooth muscle tissue—Barrett's esophagus	0.00171	0.0176	CbGeAlD
Regorafenib—Neutropenia—Esomeprazole—Barrett's esophagus	0.00162	0.00897	CcSEcCtD
Regorafenib—Neutropenia—Omeprazole—Barrett's esophagus	0.00162	0.00897	CcSEcCtD
Regorafenib—Weight decreased—Esomeprazole—Barrett's esophagus	0.00157	0.00868	CcSEcCtD
Regorafenib—Weight decreased—Omeprazole—Barrett's esophagus	0.00157	0.00868	CcSEcCtD
Regorafenib—KIT—digestive system—Barrett's esophagus	0.00155	0.016	CbGeAlD
Regorafenib—Infestation—Omeprazole—Barrett's esophagus	0.00154	0.00856	CcSEcCtD
Regorafenib—Infestation NOS—Omeprazole—Barrett's esophagus	0.00154	0.00856	CcSEcCtD
Regorafenib—Infestation—Esomeprazole—Barrett's esophagus	0.00154	0.00856	CcSEcCtD
Regorafenib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00154	0.00856	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00153	0.00848	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00153	0.00848	CcSEcCtD
Regorafenib—PDGFRB—digestive system—Barrett's esophagus	0.00151	0.0156	CbGeAlD
Regorafenib—Stomatitis—Esomeprazole—Barrett's esophagus	0.0015	0.00834	CcSEcCtD
Regorafenib—Stomatitis—Omeprazole—Barrett's esophagus	0.0015	0.00834	CcSEcCtD
Regorafenib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00146	0.00809	CcSEcCtD
Regorafenib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00146	0.00809	CcSEcCtD
Regorafenib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00137	0.00758	CcSEcCtD
Regorafenib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00137	0.00758	CcSEcCtD
Regorafenib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00136	0.00755	CcSEcCtD
Regorafenib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00136	0.00755	CcSEcCtD
Regorafenib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00136	0.00753	CcSEcCtD
Regorafenib—Urethral disorder—Omeprazole—Barrett's esophagus	0.00136	0.00753	CcSEcCtD
Regorafenib—ABL1—digestive system—Barrett's esophagus	0.00135	0.0139	CbGeAlD
Regorafenib—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00131	0.00726	CcSEcCtD
Regorafenib—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00131	0.00726	CcSEcCtD
Regorafenib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00125	0.00692	CcSEcCtD
Regorafenib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00125	0.00692	CcSEcCtD
Regorafenib—Alopecia—Omeprazole—Barrett's esophagus	0.00122	0.00679	CcSEcCtD
Regorafenib—Alopecia—Esomeprazole—Barrett's esophagus	0.00122	0.00679	CcSEcCtD
Regorafenib—Malnutrition—Esomeprazole—Barrett's esophagus	0.00121	0.00669	CcSEcCtD
Regorafenib—Malnutrition—Omeprazole—Barrett's esophagus	0.00121	0.00669	CcSEcCtD
Regorafenib—Tremor—Omeprazole—Barrett's esophagus	0.00113	0.00626	CcSEcCtD
Regorafenib—Tremor—Esomeprazole—Barrett's esophagus	0.00113	0.00626	CcSEcCtD
Regorafenib—Anaemia—Omeprazole—Barrett's esophagus	0.00111	0.00618	CcSEcCtD
Regorafenib—Anaemia—Esomeprazole—Barrett's esophagus	0.00111	0.00618	CcSEcCtD
Regorafenib—Leukopenia—Omeprazole—Barrett's esophagus	0.00108	0.00598	CcSEcCtD
Regorafenib—Leukopenia—Esomeprazole—Barrett's esophagus	0.00108	0.00598	CcSEcCtD
Regorafenib—Hypertension—Esomeprazole—Barrett's esophagus	0.00104	0.00577	CcSEcCtD
Regorafenib—Hypertension—Omeprazole—Barrett's esophagus	0.00104	0.00577	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00102	0.00565	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00102	0.00565	CcSEcCtD
Regorafenib—Dry mouth—Esomeprazole—Barrett's esophagus	0.001	0.00557	CcSEcCtD
Regorafenib—Dry mouth—Omeprazole—Barrett's esophagus	0.001	0.00557	CcSEcCtD
Regorafenib—CYP2C19—digestive system—Barrett's esophagus	0.001	0.0103	CbGeAlD
Regorafenib—Infection—Omeprazole—Barrett's esophagus	0.000978	0.00542	CcSEcCtD
Regorafenib—Infection—Esomeprazole—Barrett's esophagus	0.000978	0.00542	CcSEcCtD
Regorafenib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000965	0.00535	CcSEcCtD
Regorafenib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000965	0.00535	CcSEcCtD
Regorafenib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000964	0.00534	CcSEcCtD
Regorafenib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000964	0.00534	CcSEcCtD
Regorafenib—Skin disorder—Omeprazole—Barrett's esophagus	0.000956	0.0053	CcSEcCtD
Regorafenib—Skin disorder—Esomeprazole—Barrett's esophagus	0.000956	0.0053	CcSEcCtD
Regorafenib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000856	0.00474	CcSEcCtD
Regorafenib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000856	0.00474	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00085	0.00471	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00085	0.00471	CcSEcCtD
Regorafenib—Fatigue—Esomeprazole—Barrett's esophagus	0.000849	0.0047	CcSEcCtD
Regorafenib—Fatigue—Omeprazole—Barrett's esophagus	0.000849	0.0047	CcSEcCtD
Regorafenib—Pain—Esomeprazole—Barrett's esophagus	0.000842	0.00467	CcSEcCtD
Regorafenib—Pain—Omeprazole—Barrett's esophagus	0.000842	0.00467	CcSEcCtD
Regorafenib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000805	0.00446	CcSEcCtD
Regorafenib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000805	0.00446	CcSEcCtD
Regorafenib—CYP2B6—digestive system—Barrett's esophagus	0.000784	0.00809	CbGeAlD
Regorafenib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000778	0.00431	CcSEcCtD
Regorafenib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000778	0.00431	CcSEcCtD
Regorafenib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000778	0.00431	CcSEcCtD
Regorafenib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000778	0.00431	CcSEcCtD
Regorafenib—CYP2C9—digestive system—Barrett's esophagus	0.000777	0.00801	CbGeAlD
Regorafenib—Asthenia—Omeprazole—Barrett's esophagus	0.000706	0.00391	CcSEcCtD
Regorafenib—Asthenia—Esomeprazole—Barrett's esophagus	0.000706	0.00391	CcSEcCtD
Regorafenib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000673	0.00373	CcSEcCtD
Regorafenib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000673	0.00373	CcSEcCtD
Regorafenib—Vomiting—Omeprazole—Barrett's esophagus	0.000626	0.00347	CcSEcCtD
Regorafenib—Vomiting—Esomeprazole—Barrett's esophagus	0.000626	0.00347	CcSEcCtD
Regorafenib—Rash—Omeprazole—Barrett's esophagus	0.000621	0.00344	CcSEcCtD
Regorafenib—Rash—Esomeprazole—Barrett's esophagus	0.000621	0.00344	CcSEcCtD
Regorafenib—Dermatitis—Esomeprazole—Barrett's esophagus	0.00062	0.00344	CcSEcCtD
Regorafenib—Dermatitis—Omeprazole—Barrett's esophagus	0.00062	0.00344	CcSEcCtD
Regorafenib—Headache—Omeprazole—Barrett's esophagus	0.000617	0.00342	CcSEcCtD
Regorafenib—Headache—Esomeprazole—Barrett's esophagus	0.000617	0.00342	CcSEcCtD
Regorafenib—CYP3A4—digestive system—Barrett's esophagus	0.000592	0.00611	CbGeAlD
Regorafenib—Nausea—Esomeprazole—Barrett's esophagus	0.000585	0.00324	CcSEcCtD
Regorafenib—Nausea—Omeprazole—Barrett's esophagus	0.000585	0.00324	CcSEcCtD
Regorafenib—ABCB1—epithelium—Barrett's esophagus	0.000551	0.00569	CbGeAlD
Regorafenib—ABCB1—digestive system—Barrett's esophagus	0.000419	0.00433	CbGeAlD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000103	0.000939	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000102	0.000937	CbGpPWpGaD
Regorafenib—PDGFRB—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000101	0.000923	CbGpPWpGaD
Regorafenib—ABL1—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	0.0001	0.000918	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.0001	0.000918	CbGpPWpGaD
Regorafenib—MAPK11—Cellular responses to stress—CDKN2A—Barrett's esophagus	9.91e-05	0.000906	CbGpPWpGaD
Regorafenib—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.91e-05	0.000906	CbGpPWpGaD
Regorafenib—NTRK1—MAPK Signaling Pathway—TP53—Barrett's esophagus	9.74e-05	0.000891	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	9.63e-05	0.000881	CbGpPWpGaD
Regorafenib—MAPK11—Cellular responses to stress—RELA—Barrett's esophagus	9.54e-05	0.000872	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—RELA—Barrett's esophagus	9.54e-05	0.000872	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	9.48e-05	0.000867	CbGpPWpGaD
Regorafenib—PDGFRB—B Cell Activation—RELA—Barrett's esophagus	9.35e-05	0.000854	CbGpPWpGaD
Regorafenib—RAF1—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	9.19e-05	0.00084	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	9.1e-05	0.000832	CbGpPWpGaD
Regorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	9e-05	0.000823	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	9e-05	0.000823	CbGpPWpGaD
Regorafenib—MAPK11—Cellular responses to stress—CXCL8—Barrett's esophagus	8.99e-05	0.000822	CbGpPWpGaD
Regorafenib—MAPK11—Signaling by NGF—RELA—Barrett's esophagus	8.95e-05	0.000818	CbGpPWpGaD
Regorafenib—BRAF—Signaling by NGF—RELA—Barrett's esophagus	8.86e-05	0.00081	CbGpPWpGaD
Regorafenib—ABL1—Cell Cycle—TP53—Barrett's esophagus	8.84e-05	0.000809	CbGpPWpGaD
Regorafenib—NTRK1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	8.79e-05	0.000804	CbGpPWpGaD
Regorafenib—BRAF—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	8.54e-05	0.000781	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.46e-05	0.000774	CbGpPWpGaD
Regorafenib—NTRK1—Circadian rythm related genes—TP53—Barrett's esophagus	8.44e-05	0.000772	CbGpPWpGaD
Regorafenib—ABL1—DNA Damage Response (only ATM dependent)—TP53—Barrett's esophagus	8.39e-05	0.000767	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—GAST—Barrett's esophagus	8.34e-05	0.000763	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—PPARG—Barrett's esophagus	8.3e-05	0.000759	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	8.23e-05	0.000752	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—RELA—Barrett's esophagus	8.21e-05	0.000751	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—SST—Barrett's esophagus	8.12e-05	0.000743	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—RELA—Barrett's esophagus	8.07e-05	0.000737	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTGES—Barrett's esophagus	8.02e-05	0.000733	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTGES—Barrett's esophagus	8.02e-05	0.000733	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	7.94e-05	0.000726	CbGpPWpGaD
Regorafenib—RAF1—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	7.9e-05	0.000723	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—GAST—Barrett's esophagus	7.89e-05	0.000721	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—GAST—Barrett's esophagus	7.87e-05	0.000719	CbGpPWpGaD
Regorafenib—BRAF—MAPK Signaling Pathway—TP53—Barrett's esophagus	7.84e-05	0.000717	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.72e-05	0.000705	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—RELA—Barrett's esophagus	7.66e-05	0.0007	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—RELA—Barrett's esophagus	7.64e-05	0.000698	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	7.63e-05	0.000697	CbGpPWpGaD
Regorafenib—BRAF—Disease—SLC9A1—Barrett's esophagus	7.35e-05	0.000672	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—HGF—Barrett's esophagus	7.32e-05	0.000669	CbGpPWpGaD
Regorafenib—MAPK11—Cellular Senescence—TP53—Barrett's esophagus	7.3e-05	0.000667	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—PPARG—Barrett's esophagus	7.14e-05	0.000652	CbGpPWpGaD
Regorafenib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—Barrett's esophagus	7.03e-05	0.000642	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	7e-05	0.00064	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—RELA—Barrett's esophagus	6.88e-05	0.000629	CbGpPWpGaD
Regorafenib—FGFR2—Disease—SLC9A1—Barrett's esophagus	6.82e-05	0.000623	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTGES—Barrett's esophagus	6.8e-05	0.000622	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—GAST—Barrett's esophagus	6.78e-05	0.00062	CbGpPWpGaD
Regorafenib—FGFR1—MAPK Signaling Pathway—TP53—Barrett's esophagus	6.78e-05	0.000619	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—PPARG—Barrett's esophagus	6.76e-05	0.000618	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—RELA—Barrett's esophagus	6.72e-05	0.000614	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—GAST—Barrett's esophagus	6.72e-05	0.000614	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—HGF—Barrett's esophagus	6.69e-05	0.000612	CbGpPWpGaD
Regorafenib—KIT—Disease—SLC9A1—Barrett's esophagus	6.69e-05	0.000612	CbGpPWpGaD
Regorafenib—RAF1—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	6.58e-05	0.000602	CbGpPWpGaD
Regorafenib—ABL1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	6.46e-05	0.000591	CbGpPWpGaD
Regorafenib—TEK—Hemostasis—TP53—Barrett's esophagus	6.36e-05	0.000582	CbGpPWpGaD
Regorafenib—FGFR1—Disease—SLC9A1—Barrett's esophagus	6.35e-05	0.000581	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—SLC9A1—Barrett's esophagus	6.34e-05	0.000579	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	6.24e-05	0.00057	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—GAST—Barrett's esophagus	6.23e-05	0.000569	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—RELA—Barrett's esophagus	6.13e-05	0.000561	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	6.11e-05	0.000559	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—GAST—Barrett's esophagus	6.11e-05	0.000559	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—PPARG—Barrett's esophagus	6.11e-05	0.000558	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	6.1e-05	0.000558	CbGpPWpGaD
Regorafenib—PDGFRB—MAPK Signaling Pathway—TP53—Barrett's esophagus	6.09e-05	0.000557	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CYP26A1—Barrett's esophagus	6.08e-05	0.000556	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CYP26A1—Barrett's esophagus	6.08e-05	0.000556	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—GAST—Barrett's esophagus	5.8e-05	0.000531	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—GAST—Barrett's esophagus	5.79e-05	0.000529	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—RELA—Barrett's esophagus	5.78e-05	0.000528	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—APC—Barrett's esophagus	5.76e-05	0.000527	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—SST—Barrett's esophagus	5.72e-05	0.000523	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—SLC9A1—Barrett's esophagus	5.71e-05	0.000522	CbGpPWpGaD
Regorafenib—MAPK11—Cellular responses to stress—TP53—Barrett's esophagus	5.52e-05	0.000504	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—TP53—Barrett's esophagus	5.43e-05	0.000496	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—SST—Barrett's esophagus	5.4e-05	0.000494	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—SST—Barrett's esophagus	5.39e-05	0.000493	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.35e-05	0.00049	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—PPARG—Barrett's esophagus	5.35e-05	0.000489	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—PTGS2—Barrett's esophagus	5.32e-05	0.000486	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—GAST—Barrett's esophagus	5.21e-05	0.000477	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	5.16e-05	0.000471	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—HGF—Barrett's esophagus	5.12e-05	0.000468	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	5.11e-05	0.000467	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—RELA—Barrett's esophagus	5.1e-05	0.000466	CbGpPWpGaD
Regorafenib—RAF1—Disease—SLC9A1—Barrett's esophagus	5.09e-05	0.000465	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTGES—Barrett's esophagus	4.99e-05	0.000456	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—RELA—Barrett's esophagus	4.94e-05	0.000452	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.9e-05	0.000448	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—PPARG—Barrett's esophagus	4.89e-05	0.000447	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—HGF—Barrett's esophagus	4.7e-05	0.00043	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—RELA—Barrett's esophagus	4.68e-05	0.000428	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—SST—Barrett's esophagus	4.65e-05	0.000425	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—GAST—Barrett's esophagus	4.65e-05	0.000425	CbGpPWpGaD
Regorafenib—KIT—Immune System—HGF—Barrett's esophagus	4.62e-05	0.000422	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—SST—Barrett's esophagus	4.6e-05	0.000421	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—RELA—Barrett's esophagus	4.6e-05	0.000421	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—RELA—Barrett's esophagus	4.5e-05	0.000412	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—RELA—Barrett's esophagus	4.5e-05	0.000411	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	4.49e-05	0.000411	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—RELA—Barrett's esophagus	4.42e-05	0.000404	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—HGF—Barrett's esophagus	4.38e-05	0.000401	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—SLC9A1—Barrett's esophagus	4.38e-05	0.000401	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—SLC9A1—Barrett's esophagus	4.38e-05	0.000401	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—HGF—Barrett's esophagus	4.37e-05	0.0004	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—RELA—Barrett's esophagus	4.37e-05	0.000399	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—RELA—Barrett's esophagus	4.36e-05	0.000398	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—RELA—Barrett's esophagus	4.33e-05	0.000396	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—APC—Barrett's esophagus	4.3e-05	0.000393	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.29e-05	0.000392	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—SST—Barrett's esophagus	4.27e-05	0.00039	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—CXCL8—Barrett's esophagus	4.24e-05	0.000388	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGES—Barrett's esophagus	4.22e-05	0.000386	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—RELA—Barrett's esophagus	4.19e-05	0.000383	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—SST—Barrett's esophagus	4.19e-05	0.000383	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—RELA—Barrett's esophagus	4.18e-05	0.000382	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—SST—Barrett's esophagus	3.98e-05	0.000364	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—SST—Barrett's esophagus	3.97e-05	0.000363	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—RELA—Barrett's esophagus	3.96e-05	0.000362	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—HGF—Barrett's esophagus	3.94e-05	0.00036	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—RELA—Barrett's esophagus	3.92e-05	0.000359	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.88e-05	0.000355	CbGpPWpGaD
Regorafenib—ABL1—Immune System—HGF—Barrett's esophagus	3.84e-05	0.000351	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—RELA—Barrett's esophagus	3.82e-05	0.00035	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	3.78e-05	0.000346	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGES—Barrett's esophagus	3.77e-05	0.000345	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—RELA—Barrett's esophagus	3.77e-05	0.000344	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	3.72e-05	0.00034	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGES—Barrett's esophagus	3.68e-05	0.000336	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—PPARG—Barrett's esophagus	3.65e-05	0.000334	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—SST—Barrett's esophagus	3.57e-05	0.000327	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.53e-05	0.000323	CbGpPWpGaD
Regorafenib—RAF1—Immune System—HGF—Barrett's esophagus	3.51e-05	0.000321	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—RELA—Barrett's esophagus	3.5e-05	0.00032	CbGpPWpGaD
Regorafenib—BRAF—Disease—APC—Barrett's esophagus	3.48e-05	0.000318	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGES—Barrett's esophagus	3.44e-05	0.000314	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—RELA—Barrett's esophagus	3.36e-05	0.000307	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—RELA—Barrett's esophagus	3.36e-05	0.000307	CbGpPWpGaD
Regorafenib—FGFR2—Disease—APC—Barrett's esophagus	3.22e-05	0.000295	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	3.2e-05	0.000293	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—SST—Barrett's esophagus	3.19e-05	0.000291	CbGpPWpGaD
Regorafenib—KIT—Disease—APC—Barrett's esophagus	3.17e-05	0.000289	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—CXCL8—Barrett's esophagus	3.16e-05	0.000289	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—APC—Barrett's esophagus	3.03e-05	0.000277	CbGpPWpGaD
Regorafenib—FGFR1—Disease—APC—Barrett's esophagus	3e-05	0.000275	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—APC—Barrett's esophagus	3e-05	0.000274	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—RELA—Barrett's esophagus	2.97e-05	0.000272	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—APC—Barrett's esophagus	2.86e-05	0.000261	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.86e-05	0.000261	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.79e-05	0.000255	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—RELA—Barrett's esophagus	2.73e-05	0.000249	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	2.72e-05	0.000249	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—APC—Barrett's esophagus	2.7e-05	0.000247	CbGpPWpGaD
Regorafenib—KIT—Immune System—RELA—Barrett's esophagus	2.68e-05	0.000245	CbGpPWpGaD
Regorafenib—BRAF—Disease—PTGS2—Barrett's esophagus	2.64e-05	0.000241	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.6e-05	0.000238	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—TP53—Barrett's esophagus	2.6e-05	0.000238	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—RELA—Barrett's esophagus	2.54e-05	0.000233	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—RELA—Barrett's esophagus	2.54e-05	0.000232	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—APC—Barrett's esophagus	2.46e-05	0.000225	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—TP53—Barrett's esophagus	2.46e-05	0.000225	CbGpPWpGaD
Regorafenib—FGFR2—Disease—PTGS2—Barrett's esophagus	2.45e-05	0.000224	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—APC—Barrett's esophagus	2.44e-05	0.000223	CbGpPWpGaD
Regorafenib—RAF1—Disease—APC—Barrett's esophagus	2.41e-05	0.00022	CbGpPWpGaD
Regorafenib—KIT—Disease—PTGS2—Barrett's esophagus	2.4e-05	0.00022	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—RELA—Barrett's esophagus	2.36e-05	0.000216	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.36e-05	0.000216	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.31e-05	0.000211	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	2.31e-05	0.000211	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—RELA—Barrett's esophagus	2.29e-05	0.000209	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PTGS2—Barrett's esophagus	2.28e-05	0.000209	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PTGS2—Barrett's esophagus	2.28e-05	0.000208	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.27e-05	0.000207	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—APC—Barrett's esophagus	2.26e-05	0.000206	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—TP53—Barrett's esophagus	2.25e-05	0.000205	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—RELA—Barrett's esophagus	2.23e-05	0.000204	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CXCL8—Barrett's esophagus	2.23e-05	0.000204	CbGpPWpGaD
Regorafenib—ABL1—Immune System—RELA—Barrett's esophagus	2.23e-05	0.000204	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—APC—Barrett's esophagus	2.22e-05	0.000203	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.11e-05	0.000193	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CXCL8—Barrett's esophagus	2.11e-05	0.000193	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—APC—Barrett's esophagus	2.1e-05	0.000192	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CXCL8—Barrett's esophagus	2.1e-05	0.000192	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—APC—Barrett's esophagus	2.1e-05	0.000192	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	2.06e-05	0.000188	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PTGS2—Barrett's esophagus	2.05e-05	0.000187	CbGpPWpGaD
Regorafenib—RAF1—Immune System—RELA—Barrett's esophagus	2.04e-05	0.000186	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	2.01e-05	0.000184	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PPARG—Barrett's esophagus	2e-05	0.000183	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PPARG—Barrett's esophagus	2e-05	0.000183	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TP53—Barrett's esophagus	1.94e-05	0.000178	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.92e-05	0.000176	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—RELA—Barrett's esophagus	1.92e-05	0.000176	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—RELA—Barrett's esophagus	1.9e-05	0.000174	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—APC—Barrett's esophagus	1.89e-05	0.000173	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.88e-05	0.000172	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.86e-05	0.00017	CbGpPWpGaD
Regorafenib—RAF1—Disease—PTGS2—Barrett's esophagus	1.83e-05	0.000167	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CXCL8—Barrett's esophagus	1.81e-05	0.000166	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CXCL8—Barrett's esophagus	1.79e-05	0.000164	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—RELA—Barrett's esophagus	1.76e-05	0.000161	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—RELA—Barrett's esophagus	1.73e-05	0.000158	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.72e-05	0.000157	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PPARG—Barrett's esophagus	1.7e-05	0.000155	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—APC—Barrett's esophagus	1.69e-05	0.000154	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CXCL8—Barrett's esophagus	1.66e-05	0.000152	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.66e-05	0.000152	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—RELA—Barrett's esophagus	1.64e-05	0.00015	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—RELA—Barrett's esophagus	1.64e-05	0.00015	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CXCL8—Barrett's esophagus	1.63e-05	0.000149	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTGS2—Barrett's esophagus	1.57e-05	0.000144	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTGS2—Barrett's esophagus	1.57e-05	0.000144	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CXCL8—Barrett's esophagus	1.55e-05	0.000142	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CXCL8—Barrett's esophagus	1.55e-05	0.000141	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.51e-05	0.000138	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—RELA—Barrett's esophagus	1.48e-05	0.000135	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CXCL8—Barrett's esophagus	1.39e-05	0.000127	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TP53—Barrett's esophagus	1.37e-05	0.000125	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTGS2—Barrett's esophagus	1.33e-05	0.000122	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—RELA—Barrett's esophagus	1.32e-05	0.00012	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TP53—Barrett's esophagus	1.29e-05	0.000118	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PPARG—Barrett's esophagus	1.24e-05	0.000114	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CXCL8—Barrett's esophagus	1.24e-05	0.000113	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.24e-05	0.000113	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TP53—Barrett's esophagus	1.11e-05	0.000102	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TP53—Barrett's esophagus	1.1e-05	0.000101	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PPARG—Barrett's esophagus	1.05e-05	9.63e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TP53—Barrett's esophagus	1.02e-05	9.33e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TP53—Barrett's esophagus	1e-05	9.16e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	9.78e-06	8.95e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TP53—Barrett's esophagus	9.51e-06	8.69e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TP53—Barrett's esophagus	9.48e-06	8.67e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PPARG—Barrett's esophagus	9.4e-06	8.59e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PPARG—Barrett's esophagus	9.17e-06	8.39e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPARG—Barrett's esophagus	8.57e-06	7.83e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TP53—Barrett's esophagus	8.54e-06	7.81e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	8.28e-06	7.57e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TP53—Barrett's esophagus	7.62e-06	6.96e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	7.39e-06	6.76e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	7.22e-06	6.6e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	6.74e-06	6.16e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.65e-06	5.17e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.45e-06	4.06e-05	CbGpPWpGaD
